Gal1 recognizes poly-N-acetyllactosamine (LacNAc) structures in N- and O- glycans present on a selected repertoire of glycosylated receptors [23] and promotes tumor progression through mechanisms involving promotion of tumor vascularization, immunosuppression and metastasis [24–27]. The gene discussed is LGALS1; the disease is neoplasm.